303 related articles for article (PubMed ID: 27536994)
21. Clostridium difficile ribotype 176 - A predictor for high mortality and risk of nosocomial spread?
Polivkova S; Krutova M; Petrlova K; Benes J; Nyc O
Anaerobe; 2016 Aug; 40():35-40. PubMed ID: 27155489
[TBL] [Abstract][Full Text] [Related]
22. Ribotype variability of Clostridioides difficile strains in patients with hospital-acquired C. difficile infections, community-acquired C. difficile infections, and colonization with toxigenic and non-toxigenic strains of C. difficile.
Kim B; Seo MR; Kim J; Pai H
Anaerobe; 2019 Dec; 60():102086. PubMed ID: 31404682
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest China.
Dai W; Yang T; Yan L; Niu S; Zhang C; Sun J; Wang Z; Xia Y
BMC Infect Dis; 2020 Apr; 20(1):277. PubMed ID: 32293302
[TBL] [Abstract][Full Text] [Related]
24. In vitro antibiotic susceptibility profile of Clostridium difficile excluding PCR ribotype 027 outbreak strain in Hungary.
Terhes G; Maruyama A; Latkóczy K; Szikra L; Konkoly-Thege M; Princz G; Nagy E; Urbán E
Anaerobe; 2014 Dec; 30():41-4. PubMed ID: 25150212
[TBL] [Abstract][Full Text] [Related]
25. An outbreak case of Clostridium difficile-associated diarrhea among elderly inpatients of an intensive care unit of a tertiary hospital in Rio de Janeiro, Brazil.
Balassiano IT; Dos Santos-Filho J; de Oliveira MP; Ramos MC; Japiassu AM; Dos Reis AM; Brazier JS; de Oliveira Ferreira E; Domingues RM
Diagn Microbiol Infect Dis; 2010 Dec; 68(4):449-55. PubMed ID: 20884155
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
[TBL] [Abstract][Full Text] [Related]
27. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea.
Kim J; Kang JO; Pai H; Choi TY
Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765
[TBL] [Abstract][Full Text] [Related]
28. [Antimicrobial susceptibility of Clostridium difficile clinical isolates collected from 2001 to 2007 in a French university hospital].
Cattoir V; Ould-Hocine ZF; Legrand P
Pathol Biol (Paris); 2008; 56(7-8):407-11. PubMed ID: 18845403
[TBL] [Abstract][Full Text] [Related]
29. In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.
Bourgault AM; Lamothe F; Loo VG; Poirier L;
Antimicrob Agents Chemother; 2006 Oct; 50(10):3473-5. PubMed ID: 17005836
[TBL] [Abstract][Full Text] [Related]
30. Imipenem Resistance in Clostridium difficile Ribotype 017, Portugal.
Isidro J; Santos A; Nunes A; Borges V; Silva C; Vieira L; Mendes AL; Serrano M; Henriques AO; Gomes JP; Oleastro M
Emerg Infect Dis; 2018 Apr; 24(4):741-745. PubMed ID: 29553322
[TBL] [Abstract][Full Text] [Related]
31. Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection.
Suárez-Bode L; Barrón R; Pérez JL; Mena A
Anaerobe; 2019 Feb; 55():124-129. PubMed ID: 30550807
[TBL] [Abstract][Full Text] [Related]
32. Prevalence, genetic relatedness and antibiotic resistance of hospital-acquired clostridium difficile PCR ribotype 018 strains.
Seo MR; Kim J; Lee Y; Lim DG; Pai H
Int J Antimicrob Agents; 2018 May; 51(5):762-767. PubMed ID: 29408226
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.
Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC
J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147
[TBL] [Abstract][Full Text] [Related]
34. Prevalence, characteristics and antimicrobial susceptibility patterns of Clostridioides difficile isolated from hospitals in Iran.
Alimolaei M; Rahimi HR; Ezatkhah M; Shamsaddini Bafti M; Afzali S
J Glob Antimicrob Resist; 2019 Dec; 19():22-27. PubMed ID: 30825696
[TBL] [Abstract][Full Text] [Related]
35. Clostridium difficile infection in cancer patients with hospital acquired diarrhea at the teaching hospitals in Iran: Multilocus sequence typing analysis (MLST) and Antimicrobial resistance pattern.
Shoaei P; Shojaei H; Khorvash F; M Hosseini S; Ataei B; Esfandiari Z; Vakili B; Rozati M; Safavi AA
Ann Ig; 2019; 31(4):365-373. PubMed ID: 31268121
[TBL] [Abstract][Full Text] [Related]
36. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea.
Kim H; Jeong SH; Roh KH; Hong SG; Kim JW; Shin MG; Kim MN; Shin HB; Uh Y; Lee H; Lee K
Korean J Lab Med; 2010 Oct; 30(5):491-7. PubMed ID: 20890081
[TBL] [Abstract][Full Text] [Related]
37. Change in antimicrobial susceptibility and PCR ribotypes of Clostridioides difficile in a hospital over 5 years: Correlation analysis with antimicrobial consumption.
Seo MR; Kim B; Kim J; Pai H
Int J Antimicrob Agents; 2019 Aug; 54(2):154-158. PubMed ID: 31173866
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial Susceptibility Patterns of Clostridium difficile Isolates from Family Dairy Farms.
Bandelj P; Golob M; Ocepek M; Zdovc I; Vengust M
Zoonoses Public Health; 2017 May; 64(3):213-221. PubMed ID: 27484050
[TBL] [Abstract][Full Text] [Related]
39. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB
Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148
[TBL] [Abstract][Full Text] [Related]
40. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.
Khanna S; Pardi DS
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):409-16. PubMed ID: 20678014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
